Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 102270
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.102270
Table 1 Baseline demographic and clinical characteristics, n (%)
Characteristics
Without cirrhosis
With cirrhosis
P value
Total14605 (98)315 (2)
Female6718 (85)104 (15)0.03
Mean age, years52.752.3
Charlson comorbidity index score< 0.01
03651 (25)0 (0)
13943 (27)69 (22)
22774 (19)66 (21)
≥ 34235 (29)179 (57)
Insurance type0.73
Medicare4673 (32)94 (30)
Medicaid4527 (31)116 (37)
Private insurance3943 (27)81 (26)
Self-pay1460 (10)22 (7)
Comorbidities
Sepsis2190 (15)69 (22)0.14
Diabetes mellitus8032 (40)126 (55)0.015
Hypertension8470 (58)176 (56)0.67
Obesity5257 (36)110 (35)0.88
Chronic kidney disease1898 (13)78 (25)< 0.01
Alcohol use disorder438 (3)75 (24)< 0.01
Chronic obstructive pulmonary disease1460 (10)53 (17)0.5
Chronic heart failure730 (5)9 (3)0.45
Coronary artery disease1898 (13)40 (13)0.38
Gastroesophageal reflux disease1898 (13)53 (17)0.38
Cigarette smoking4089 (28)113 (36)0.13
Table 2 Primary and secondary in-hospital outcomes of cirrhotic vs non-cirrhotic patients, n (%)
Total
Without cirrhosis
With cirrhosis
P value
Adjusted odds ratio1
P value
Confidence interval
In-hospital mortality rates and odds
460 (3)430 (3)30 (9.5)< 0.013.780.021.23-11.5
In-hospital septic shock rates and odds
200 (5)715 (4.9)33 (10.5)0.2625.6< 0.014.13-159.4
In-hospital surgical amputation rates and odds
1105 (7.4)1066 (7.3)30 (9.5)0.51.150.770.43-3.08
Table 3 In hospital lengths of stay and charges in cirrhotic vs non-cirrhotic patients
Without cirrhosis
With cirrhosis
Adjusted means
P value
Length of stay means and adjusted means, days1
12.216.81.110.5
Total charges and adjusted means, dollars
152169237775461520.29